Trials / Unknown
UnknownNCT03475407
The Effects of Intravitreal Ozurdex Implant in DME
The Effects of Intravitral Ozurdex Implant in DME: Cytokine Change in Aqueous Humor
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Nune Eye Hospital, Seoul, Korea · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Intravitreal Ozurdex implant therapy improves visual outcome and OCT findings. The purpose of this study is that these results are correlated with the change of cytokine level known to be increased in DME patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ozurdex intravitreal injection | 1. Ozurdex intravitreal injection and Antreior Chamber(AC) paracentesis at baseline 2. AC paracentesis at 6 wk 3. intravitreal Ozurdex injection and AC paracentesis at 18wk or 24wk |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2018-06-01
- Completion
- 2018-12-01
- First posted
- 2018-03-23
- Last updated
- 2018-03-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03475407. Inclusion in this directory is not an endorsement.